Axq Capital »

4d Molecular Therapeutics In shares owned by Axq Capital

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Axq Capital from 13F filings

Historical chart of Axq Capital investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Axq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Axq Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $112k 13k 8.69
2024-12-31 $110k 20k 5.57

More positions owned by Axq Capital

Dover Corporation (DOV)
Arista Networks Com Shs (ANET)
Vistra Energy (VST)
Palantir Technologies Cl A (PLTR)
3M Company (MMM)
Honeywell International (HON)
Bristol Myers Squibb (BMY)
Amphenol Corp Cl A (APH)
Godaddy Cl A (GDDY)
EOG Resources (EOG)
Interactive Brokers Group In Com Cl A (IBKR)
Prudential Financial (PRU)
Gilead Sciences (GILD)
Cardinal Health (CAH)
Huntsman Corporation (HUN)

View all positions for Axq Capital

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Vanguard Group
Novo A/S
Henderson Group
Federated Investors
Millennium Management
Armistice Capital
Morgan Stanley
Geode Capital Management
State Street Corporation
Assenagon Asset Management
Two Sigma Advisers

View all funds holding 4d Molecular Therapeutics In